期刊文献+

白细胞介素10对脑缺血大鼠的神经保护作用 被引量:4

Neuroprotective effect of interleukin-10 in rats with cerebral ischemia
下载PDF
导出
摘要 目的:观察白细胞介素10对大鼠缺血性脑损伤的保护作用,并比较侧脑室和尾静脉注入两种给药方式的效果。方法:实验于南方医科大学附属南方医院神经内科实验室内进行。①将60只清洁级SD大鼠随机分为3组(n=20),所有大鼠均采用三氯化铁化学诱导法制作大脑中动脉血栓闭塞模型,造模4h后进行神经症状评分(评分越低提示脑损害越轻,越高提示脑损害越严重)。②评分后侧脑室注射组大鼠右侧侧脑室注射20mg/L的白细胞介素101μg/kg,注射速度为15μg/h;尾静脉注射组大鼠尾静脉注射20mg/L白细胞介素101μg/kg,注射速度为15μg/h;对照组大鼠右侧侧脑室注射等体积生理盐水。③给药后24h再次进行神经症状评分,然后断头处死大鼠取脑,测量各组大鼠脑梗死范围。结果:60只大鼠进入结果分析。①脑梗死范围:侧脑室注射组和尾静脉注射组均显著小于对照组[(2.47±0.51)%,(2.43±0.62)%,(3.29±0.78)%,P<0.01],但两组间无差异。②神经症状评分:给药前3组无差异(P>0.05),给药后侧脑室注射组和尾静脉注射组均显著低于对照组(2.32±0.72,2.43±0.62,3.29±0.78,P<0.01),但两组间无差异。结论:无论侧脑室还是尾静脉注入白细胞介素10均可显著缩小急性缺血性大鼠的脑梗死面积并减轻脑梗死症状,两种给药方式无差异。提示白细胞介素10对大鼠脑缺血有明显的神经保护作用。 AIM: To observe the protective effect of interleukin-10 on ischemic brainin jury of rats, and compare the effects of lateral ventricle administration with caudal vein administration. METHODS: The experiment was carried out in the Laboratary of Neurology, Affiliated Nanfang Hospital, Southern Medical University. (1)Sixty SD rats of clearing grade were randomly divided into 3 groups (n=20). All rats were made into models of thrombus emphraxis in middle cerebral artery (MCA) with ferric chloride chemical derivation. Nerve-symptom scores were evaluated 4 days after modeling (lower score suggested slight brain lesion, higher score suggested heavy brain lesion). (2) After scores were evaluated, rats in the lateral-ventricle injection group were injected with 20mg/L interleukin-10 (1μg/kg) through the right lateral ventricle at the injecting rate of 15μg per hour; Rats in the caudal-vein injection group were injected with 20 mg/L interleukin-10 (1μg/kg) through the caudal vein at the injecting rate of 15 μg per hour; Rats in the control group were injected with normal saline of the same volum through the right lateral ventricle (3)Scores of nerve symptoms were re-evaluated 24 hours after administration, then rats were killed to take out brain tissue, and cerebral infarction area in rats were measured. RSULTS: Sixty rats were involved in the analysis of results. (1)Cerebral infarct area: It was significantly smaller in the lateral-ventricle injection group and the caudal-vein injection group than that in the control group [(2.47~0.51 )%, (2.43~0.62)%, (3.29~0.78)%, P〈0. 01], and there was no difference between the former two groups. (2)Nerve-symptom scores: There was no difference among the 3 groups before administration (P〉 0.05). After administration, it was obviously lower in the lateral-ventricle injection group and the candal-vein injection group than that in the control group (2.32±0.72,2.43±0.62,3.29±0.78, P 〈 0.01),and there was no difference between the former two groups. CONCLUSION: Injection of interleukin-10 through both lateral ventricle and caudal vein can significantly decrease the infarction area of rats with acute cerebral isehemia, and there is no difference between the two administration ways, which indicates that interleukin-10 has a significant neuroproteetive effect on cerebral ischemia of rats.
出处 《中国临床康复》 CSCD 北大核心 2005年第45期52-54,共3页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献15

  • 1Li HL,Kostulas N,Huang YM,et al.IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat.J Neuroimmunol 2001:116(1):5-14.
  • 2陈荣华,刘楠,郑安,余秀萍,黄华品.局灶性脑缺血大鼠白细胞介素10的变化[J].中国动脉硬化杂志,2003,11(7):622-624. 被引量:9
  • 3Tamura A,Graham DI,McCulloch J,et al.Focal Cerebral ischemia in the rat.1.Description of technique and early neuropathological consequences following middle Cerebral artery occlusion.J Cereb Blood Flow Metab 1981;1(1):53-60.
  • 4刘小光,徐理纳.一种能评价溶拴和抗栓药的大鼠大脑中动脉血栓模型[J].药学学报,1995,30(9):662-667. 被引量:103
  • 5Bederson JB,Pitts LH,Tsuji M,et al.Rat middle cerebral artery occlusion:evaluation of the model and development of a neurologic examination.Stroke 1986;17(3):472-6.
  • 6Lundy EF,Solik BS,Frank RS,et al.Morphometric evaluation of brain infarcts in rats and gerbils.J Pharmacol Methods 1986;16(3):201-14.
  • 7Mallat Z,Heymes C,Ohan J,et al.Expression of interleukin-10 in advanced human atherosclerotic plaques:relation to inducible nitric oxide synthase expression and cell death.Arterioscler Thromb Vasc Biol 1999;19(3):611-6.
  • 8Stoll G,Jander S,Schroeter M.Inflammation and glial responses in ischemic brain lesions.Prog Neurobiol 1998;56(2):149-71.
  • 9Catto AJ,Carter AM,Stickland M,et al.Plasminogen activator inhibitor-1(PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.Thromb Haemost 1997;77(4):730-4.
  • 10卢斌,卢大儒,邹大进.白细胞介素10基因对非肥胖糖尿病鼠1型糖尿病发病率的影响[J].中国临床康复,2005,9(3):98-99. 被引量:15

二级参考文献30

  • 1[1]Perini F, Morra M, Alecci M, et al. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci, 2001, 22:289-296.
  • 2[2]Spera PA, Ellison JA, Feuerstein GZ, et al. IL-10 reduces rat brain injury following focal stroke. Neuroscience Letter,1998,251: 189-192.
  • 3[3]Gunnett GA, Berg DJ, Faraci FM, et al. Vascular effect of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke, 1999, 30: 2191-2196.
  • 4[4]Grilli M, Barbieri I, Basudev H, et al. Interleukin-10modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci , 2000 , 12: 2265-2272.
  • 5陈荣华,刘楠,郑安,等.大鼠脑缺血后IL-10变化研究[J].中国动脉硬化杂志,2003,(11):471-473.
  • 6[6]Longa EZ, Weinstein PR, Carlson S, et al. Rewersible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989,20: 84-91.
  • 7[8]Stephen Ashwal Beatriz Tone BA. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke, 1998, 29: 1037-1047.
  • 8[9]Beray-Berthat V, Palmier B, Plotkine M, et al. Neutrophils do not contribute to infarction, oxidative stress, and NO synthase activity in severe brain ischemia. Exp Neurol,2003, 182: 446-454.
  • 9[10]Franklin A, Parmentier-Batteur S, Walter L, et al. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci, 2003 , 23:7767-7775.
  • 10[11]Hibuta S, Varathan S, Mashimo T. The neuroprotective effect of ONO-1714 on NMDA-mediated cytotoxicity in vitro. J NeurolSc, 2003 , 215: 31-36.

共引文献134

同被引文献33

  • 1周毅虹,唐兰芬,敖当,钟巨斌,苏赞彩,揭育丽.新生儿缺氧缺血性脑病血清细胞因子水平的研究[J].中国优生与遗传杂志,2004,12(4):92-93. 被引量:15
  • 2奚玉凤,刘媛媛.针灸治疗脑卒中的方法及应用要点[J].中国临床康复,2005,9(17):172-174. 被引量:6
  • 3[1]Pinderski Oslund LJ,Hedrick CC,Olvera T,et al.Interleukin-10 blocks atherosclerotic events in vitro and in vivo[J].Arterioscler Thromb Vasc Biol,1999,19:2847-2853.
  • 4[2]Terkeltaub RA.IL-10:An "immunologic scalpel" for atherosclerosis?[J].Arterioscler Thromb Vasc Biol,1999,19:2823-2825.
  • 5[3]Koch W,Kastrati A,Bottiger C,et al.Interleukin-10and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction[J].Atherosclerosis,2001,159:137-144.
  • 6[4]Mallat Z,Heymes C,Ohan J,et al.Expression of interleukin-10 in advanced human atherosclerotic plaques:relation to inducible nitric oxide synthase expression and cell death[J].Arterioscler Thromb Vasc Biol,1999,19:611-616.
  • 7[5]Dewberry R,Holden H,Crossman D,et al.Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis[J].Arterioscler Thromb Vasc Biol,2000,20:2394-2400.
  • 8[6]Kucharzik T,Lugering N,Panels HG,et al.IL-4,IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1(MCP-1)production in activated intestinal epithelial cells[J].Clin Exp Immunol,1998,111:152-167.
  • 9[7]Gosling J,Slaymaker S,Gu L,et al.MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B[J].J Clin Invest,1999.103:773-778.
  • 10[8]Li HL,Kostulas N,Huang YM,et al.IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat[J].Neuroimmunol,2001,116:5-14.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部